ArticleACS medicinal chemistry letters2024

Novel Compounds as NLRP3 Inhibitors for Treating Alzheimer's Disease and Parkinson's Disease.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.